# System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
> **Product code: SBB** · Class III — High Risk (PMA approval required, life-sustaining) · Unknown · —
## Classification
- **FDA Product Code:** SBB
- **Device class:** Class III — High Risk (PMA approval required, life-sustaining)
- **Regulation:** —
- **Review panel:** PA
- **Medical specialty:** Unknown
- **Submission type:** 2
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Definition

The colorectal neoplasia RNA and hemoglobin assay is a non-invasive, qualitative in vitro diagnostic intended for the detection of colorectal neoplasia associated RNA markers and for the presence of occult hemoglobin in human stool.  The test is to aid in the detection of colorectal cancer (CRC) and advanced adenomas (AA).  The test is not a replacement for diagnostic colonoscopy.  It is indicated for use in adults 45 years or older, who are typical average-risk candidates for colorectal cancer (CRC) screening.  A positive result may indicate the presence of CRC or AA and should be followed by a diagnostic colonoscopy.

## Market data
- **Cleared 510(k) submissions:** 0
- **Registered establishments:** 3
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=SBB)
---
*AI Analytics · CC0 1.0*